Voyager readies two-pronged attack on Alzheimer’s tau

Coverage, in order

1. 5d ago
   
   Longevity.Technology UK indie

   Voyager readies two-pronged attack on Alzheimer’s tau

   A gene therapy heading toward its first human trial and an antibody already in dose-escalation will each get a poster at CTAD. Drug developers keep coming at tau from different directions. Biogen’s version, diranersen , is injected into the fluid around the spinal cord to cut production of the…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.